Process Industries Asahi Kasei Corp. Business Summary
Asahi Kasei Corp. operates as a holding company which provides monitoring, planning, and strategic management to its subsidiaries and affiliates. Its operations are carried out through the following segments: Materials, Homes, Health Care, and Others. The Materials segment includes caustic soda, chlorine, acrylonitrile, styrene, methyl methacrylate, adipic acid, polyethylene, polystyrene, and other petrochemicals. The Homes segment includes "Long Life Home" products and also provides remodeling, real estate, and urban redevelopment. The Health Care segment includes pharmaceuticals and diagnostic reagents. The Others segment includes engineering, employment agency and temporary staffing services. The company was founded on May 21, 1931 and is headquartered in Tokyo, Japan.
Financial Highlights
Mar 2020
JPY USD Revenue 2,151.64B 19,789.65M Gross Profit 703,762M 6,472.81M Operating income 177,264M 1,630.37M Income before tax 155,934M 1,434.19M Net income 103,931M 955.90M EBITDA 295,568M 2,718.47M Diluted EPS 74.84 0.68 Dividends Per Share 34 0.31 Total Assets 2,797.97B 25,917.97M Total liabilities 1,414.51B 13,102.82M Total equity 1,359.31B 12,591.49M Operating cash flow 124,460M 1,144.71M Currency in JPY Currency in USD
Historical Data Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
1,940.91B
1,882.99B
2,042.21B
2,170.40B
2,151.64B
Gross Profit
606,344M
606,826M
672,802M
715,748M
703,762M
Operating income
165,203M
159,230M
198,475M
209,588M
177,264M
Income before tax
146,389M
157,388M
218,333M
210,397M
155,934M
Net income
91,754M
115,000M
170,249M
147,512M
103,931M
EBITDA
274,835M
268,423M
311,938M
313,634M
295,568M
Diluted EPS
65.69
82.34
121.92
105.65
74.84
Dividends Per Share
20
24
34
34
34
Total Assets
2,211.72B
2,254.50B
2,307.15B
2,575.20B
2,797.97B
Total liabilities
1,154.33B
1,086.38B
1,001.93B
1,172.49B
1,414.51B
Total equity
1,041.90B
1,151.34B
1,287.38B
1,381.48B
1,359.31B
Operating cash flow
216,218M
168,965M
249,891M
212,062M
124,460M
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Revenue
16,162.93M
17,388.81M
18,426.16M
19,571.75M
19,789.65M
Gross Profit
5,049.32M
5,603.84M
6,070.44M
6,454.30M
6,472.81M
Operating income
1,375.72M
1,470.43M
1,790.76M
1,889.97M
1,630.37M
Income before tax
1,219.05M
1,453.42M
1,969.93M
1,897.26M
1,434.19M
Net income
764.07M
1,061.98M
1,536.09M
1,330.19M
955.90M
EBITDA
2,288.68M
2,478.79M
2,814.50M
2,828.21M
2,718.47M
Diluted EPS
0.54
0.76
1.10
0.95
0.68
Dividends Per Share
0.16
0.22
0.30
0.30
0.31
Total Assets
19,678.17M
20,232.43M
21,693.96M
23,266.05M
25,917.97M
Total liabilities
10,270.29M
9,749.48M
9,421.12M
10,593.05M
13,102.82M
Total equity
9,269.99M
10,332.44M
12,105.18M
12,481.23M
12,591.49M
Operating cash flow
1,800.55M
1,560.33M
2,254.67M
1,912.28M
1,144.71M
Valuation Measures
Mar 2020
PER 10.21 ROA 3.86% ROE 7.58% Operating margin 8.23% Profit margin 4.83%
Key executives
Executive President & Representative Director:
Hideki Kobori
Director, Head-Information Technology & Finance:
Yutaka Shibata
General Manager-Research & Development:
Hiroshi Shirai
Head-Risk, Compliance, Legal & General Affairs:
Nobuyuki Kakizawa
Director & Executive Vice President:
Hiroshi Yoshida Shareholders
Nippon Life Insurance Co. (4.6%)
Nomura Asset Management Co., Ltd. (3.8%)
Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.7%)
Asset Management One Co., Ltd. (3.7%)
Capital Research & Management Co. (World Investors) (2.9%)
BlackRock Fund Advisors (2.6%)
Asahi Kasei Employee Stock Ownership Plan (2.4%)
The Vanguard Group, Inc. (2.2%)
Capital Research & Management Co. (Global Investors) (2.1%)
Norges Bank Investment Management (2.1%)
Related Companies
Asahi Kasei Realty & Residence Corp.
Asahi Kasei Home Products Corp.
Asahi Kasei Advance Corp.
Asahi Kasei Corp. /ACS Resin Bus/
Austin Electric Services LLC
Asahi Kasei Pharma Denmark A/S
Asahikasei Haus SSI Co. Ltd.
Polypore KK
Asahi-Schwebel Co. Ltd.
Asahi Kasei Corporate Venture Capital
Asahi Kasei Board Incentive Plan
Asahi-Schewebel Co., Ltd.
Asahi Tokyo Investment Trust Management Co., Ltd.
Asahi Kasei Europe GmbH
Asahi Kasei (China) Investment Co. Ltd.
Kyokuyo Textile (Thailand) Co. Ltd.
Asahi Kasei Synthetic Rubber Europe NV/SA
Asahi Kasei Deutschland GmbH
Asahi Kasei E-Materials Korea, Inc.
Asahi Kasei Medical Trading (Korea) Co. Ltd.
Asahi Kasei Tibbi Cihazlar Tic Ltd. Sti
Asahi Kasei (Suzhou) Plastics Compound Co. Ltd.
Asahi Kasei EMD Taiwan Corp.
Asahikasei Plastics (Hong Kong) Co. Ltd.
Asahi Kasei Fibers Italia SRL
Asahi Kasei Plastics (America), Inc.
Asahi Kasei POM (Zhangjiagang) Co. Ltd.
ASAHI KASEI MICROZA (Hangzhou) Co. Ltd.
Asahi Kasei Bioprocess Europe NV/SA
Asahi Kasei Medical Trading Taiwan Co. Ltd.
Competitors
Chemours Co.
Sumitomo Chemical Co., Ltd.
Eternal Materials Co., Ltd.
LG Chem Ltd.
Celanese Corporation
Trinseo SA
Cathay Biotech Inc. Class A
Shenma Industry Co., Ltd. Class A
NEXT SCIENCE Co.,Ltd.
Everspin Technologies, Inc.
Nephros, Inc.
CytoSorbents Corporation
Cirrus Logic, Inc.
Fresenius Medical Care AG & Co. KGaA
Sonnet BioTherapeutics Holdings, Inc.
Stryker Corporation
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 26 Feb, 2021
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more
